Katherine L. Nicholson

Author

Also Known As

K L Nicholson, K Nicholson, K. L. Nicholson, K. Nicholson, K.L. Nicholson, Katherine L. Nicholson, Katherine L Nicholson, Katherine L. Nicholson, Katherine Lynn Nicholson, Katherine Nicholson

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University Virginia Commonwealth University Medical Center Pfizer (United States)Massachusetts General Hospital University of Kentucky

About

Katherine L. Nicholson is an author at Virginia Commonwealth University specializing in neuropharmacology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	799
2	Social Sciences	12	13	610
3	Health Sciences	3	3	108
4	Behavioral Sciences	3	3	98
5	Cognitive Science	1	1	26

Katherine L. Nicholson

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects Jeffrey Burgdorf, Xiaolei Zhang, Katherine L. Nicholson, Neuropsychopharmacology PsychiatryAntidepressant-like EffectsMedicinePsychotropic MedicationPsychopharmacology	2012	279
Subunit‐specific mechanisms and proton sensitivity of NMDA receptor channel block Shashank M. Dravid, Kevin Erreger, Hongjie Yuan, The Journal of Physiology	2007	176
Failure of Δ9-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys Robert S. Mansbach, Katherine L. Nicholson, BR Martin, Behavioural Pharmacology	1994	97
Context-Dependent GluN2B-Selective Inhibitors of NMDA Receptor Function Are Neuroprotective with Minimal Side Effects Hongjie Yuan, Scott J. Myers, Gordon Wells, Neuron Minimal Side EffectsMedicineNeurotransmitterContext-dependent Glun2b-selective InhibitorsNeuropharmacology	2015	68
Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists Robert L. Balster, Robert S. Mansbach, Keith L. Shelton, Behavioural Pharmacology Molecular PharmacologyNmda DiscriminationVitro SelectivityFunctional SelectivityMedicine	1995	55
PRECLINICAL STUDY: Age‐dependent differences in sensitivity and sensitization to cannabinoids and ‘club drugs’ in male adolescent and adult rats Jenny L. Wiley, Rhys L. Evans, Darren B. Grainger, Addiction Biology NeuropsychologySubstance UsePsychopharmacologyCannabinoid PharmacologySocial Sciences	2007	53
Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys Katherine L. Nicholson, Belinda A. Hayes, Robert L. Balster Psychopharmacology Pharmacological StudyBehavioral NeuroscienceNeuroanatomyRhesus MonkeysBehavioral Pharmacology	1999	51
Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys. Joshua A. Lile, Amy R. Johnson, Matthew L. Banks, Experimental and Clinical Psychopharmacology Substance UsePsychopharmacologyCocaineD-amphetamine MaintenanceSubstance Use Disorders	2019	43
Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug Jenny L. Wiley, Rhys L. Evans, Darren B. Grainger, Pharmacological Reports Locomotor Activity ChangesSubstance UsePsychopharmacologyCannabinoid PharmacologyFemale Adolescent	2011	36
Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. Katherine L. Nicholson, Hendrée E. Jones, Robert L. Balster PubMed Molecular PharmacologyPharmacological StudyDiscriminative Stimulus PropertiesNeurophysiologyPcp-like Antagonist	1998	35

Page 1